Zhicheng Lin

5.3k total citations · 1 hit paper
131 papers, 4.0k citations indexed

About

Zhicheng Lin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Zhicheng Lin has authored 131 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 46 papers in Molecular Biology and 43 papers in Neurology. Recurrent topics in Zhicheng Lin's work include Neurotransmitter Receptor Influence on Behavior (36 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Receptor Mechanisms and Signaling (23 papers). Zhicheng Lin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (36 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Receptor Mechanisms and Signaling (23 papers). Zhicheng Lin collaborates with scholars based in United States, China and Japan. Zhicheng Lin's co-authors include Nian Xiong, George R. Uhl, Jinsha Huang, Guoxin Zhang, Jing Xiong, Chao Han, Zhentao Zhang, Wenfei Wang, Chunnuan Chen and Ling Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Zhicheng Lin

131 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects

2018 307 citations Kai Ma, Nian Xiong et al. profile →

Peers

Zhicheng Lin

MB

CMN

NEURO

PHARM

NEURO

Yong Cheng China

Xiaomin Wang China

Abolhassan Ahmadiani Iran

Yan Wu China

Maria Tiziana Corasaniti Italy

Wei Zhu China

Gloria Lazzeri Italy

Krishnan M. Dhandapani United States

Ali Gorji Germany

Thomas Fréret France

Yong Cheng China

Zhicheng Lin

1.8k ×1.2

MB

841 ×0.6

CMN

840 ×0.9

NEURO

228 ×0.5

PHARM

805 ×1.8

NEURO

Citations per year, relative to Zhicheng Lin Zhicheng Lin (= 1×) peers Yong Cheng

Countries citing papers authored by Zhicheng Lin

Since Specialization

Citations

This map shows the geographic impact of Zhicheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhicheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhicheng Lin more than expected).

Fields of papers citing papers by Zhicheng Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhicheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhicheng Lin. The network helps show where Zhicheng Lin may publish in the future.

Co-authorship network of co-authors of Zhicheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhicheng Lin. A scholar is included among the top collaborators of Zhicheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhicheng Lin. Zhicheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zhao, Weixin, Zhiyue Liu, Zhicheng Lin, et al.. (2024). A Shape-Consistent Deep-Learning Segmentation Architecture for Low-Quality and High-Interference Myocardial Contrast Echocardiography. Ultrasound in Medicine & Biology. 50(11). 1602–1610. 2 indexed citations

2.

Li, Jingwen, et al.. (2023). Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease. Antioxidants. 12(2). 396–396. 25 indexed citations

3.

Wang, Xinyi, et al.. (2023). SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments. Microorganisms. 11(3). 580–580. 3 indexed citations

4.

Li, Jingwen, et al.. (2022). Diffusion Tensor Imaging Radiomics for Diagnosis of Parkinson’s Disease. Brain Sciences. 12(7). 851–851. 9 indexed citations

5.

Li, Jingwen, Xi Long, Qing Zhang, et al.. (2022). Pearson’s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak. iScience. 25(6). 104415–104415. 1 indexed citations

6.

Li, Jingwen, Chao Duan, Lan Chen, et al.. (2022). Prevention and Control of COVID-19 after Resuming General Hospital Functions. Pathogens. 11(4). 452–452. 2 indexed citations

7.

Jiang, Wen G., Zhicheng Lin, Qinghua Ye, et al.. (2022). SMRT and Illumina RNA-Seq Identifies Potential Candidate Genes Related to the Double Flower Phenotype and Unveils SsAP2 as a Key Regulator of the Double-Flower Trait in Sagittaria sagittifolia. International Journal of Molecular Sciences. 23(4). 2240–2240. 7 indexed citations

8.

Reith, Maarten E. A., Sandhya Kortagere, Corinde E. Wiers, et al.. (2021). The dopamine transporter gene SLC6A3: multidisease risks. Molecular Psychiatry. 27(2). 1031–1046. 56 indexed citations

9.

Li, Jinghong, Xi Long, Xi Fang, et al.. (2020). Tobacco smoking confers risk for severe COVID‐19 unexplainable by pulmonary imaging. Journal of Internal Medicine. 289(4). 574–583. 14 indexed citations

10.

Li, Jingwen, Xi Long, Heqing Huang, et al.. (2020). Resilience of Alzheimer’s Disease to COVID-19. Journal of Alzheimer s Disease. 77(1). 67–73. 18 indexed citations

11.

Zhao, Juan, Yanhong Zhou, Nian Xiong, et al.. (2019). Presence of recombination hotspots throughout SLC6A3. PLoS ONE. 14(6). e0218129–e0218129. 4 indexed citations

12.

Zhao, Juan, Chunnuan Chen, Richard L. Bell, Hong Qing, & Zhicheng Lin. (2019). Identification of HIVEP2 as a dopaminergic transcription factor related to substance use disorders in rats and humans. Translational Psychiatry. 9(1). 247–247. 6 indexed citations

13.

Li, Jingwen, Xi Long, Ting Zhou, et al.. (2019). Multiple pathways for natural product treatment of Parkinson's disease: A mini review. Phytomedicine. 60. 152954–152954. 30 indexed citations

14.

Han, Chao, Nian Xiong, Xingfang Guo, et al.. (2019). Exosomes from patients with Parkinson’s disease are pathological in mice. Journal of Molecular Medicine. 97(9). 1329–1344. 76 indexed citations

15.

Luo, Cong, et al.. (2018). Transcriptome analysis of starch and sucrose metabolism across bulb development in Sagittaria sagittifolia. Gene. 649. 99–112. 31 indexed citations

16.

Liu, Kefu, Jinlong Yu, Juan Zhao, et al.. (2017). AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders. Molecular Neurobiology. 55(7). 5611–5622. 10 indexed citations

17.

Zhai, Desheng, Gaopan Dong, Yuxin Yang, et al.. (2017). The correlation between DNA methylation and transcriptional expression of human dopamine transporter in cell lines. Neuroscience Letters. 662. 91–97. 6 indexed citations

18.

Wang, Xin, Nuomin Li, Nian Xiong, et al.. (2016). Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson’s Disease. Molecular Neurobiology. 54(4). 2878–2888. 23 indexed citations

19.

Xiong, Nian, Jinsha Huang, Zhentao Zhang, et al.. (2009). Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease. PLoS ONE. 4(11). e7878–e7878. 95 indexed citations

20.

Lin, Zhicheng & Bertha K. Madras. (2006). Human Genetics and Pharmacology of Neurotransmitter Transporters. Handbook of experimental pharmacology. 327–371. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact